DelveInsight’s ‘Drug Infusion System-Market Insights, Competitive Landscape and Market Forecast - 2025’ report delivers an in-depth understanding of Drug Infusion System and the historical and forecasted Drug Infusion System market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
The Drug Infusion System market report provides an overview of Drug Infusion System, reasons to get Drug Infusion System as well as its advantages and limitations. Additionally, the report provides insight on the Drug Infusion System market share of the individual Drug Infusion System devices, current and forecasted Drug Infusion System market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.
Drug Infusion System Overview
Drug infusion systems are used in administering drugs into the body. These drugs can be an antibiotic, chemotherapy drugs, insulin, painkillers and others via intravenous, intramuscular or epidural routes in accurate manner. Consumer development is led by the rise in the prevalence of chronic diseases such as cardiovascular disease, stroke, cancer, type 2 diabetes, obesity, and arthritis. In addition, the increasing geriatric population, the introduction of technologically advanced technologies and rising expenditure on healthcare offer favourable conditions for the growth of the sector. Portability, ergonomic nature, and visual control capabilities further favour the future development of the industry because of their ease of use. Factors such as the high cost of the drug infusion system, the lack of qualified labour and stringent government legislation and product clearance regulations are however, likely to hinder business expansion.
Study Period: 2017–2025
Geography Covered
• The US
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan
List of Companies:
Medtronic
B. Braun Melsungen AG
Baxter
Arcomed AG
Halyard Health, INC
ICU Medical Inc
Insulet Corporation
Terumo Corporation
Smiths Group Plc
Tandem Diabetes Care
Drug Infusion System- Competitive Analysis
This segment of the report provides a brief competitive analysis of Drug Infusion System, to help understand the competition in the market. It gives a comparative understanding of the products based on types of wounds.
Drug Infusion System: Market Analysis
This segment illustrates the market of Drug Infusion System across 7MM and how the market is expected to rise in the study period (2017 to 2025), at a significant CAGR.
KOL- Views
To keep up with the market trends, we take KOLs and SME’s opinion working in Drug Infusion System domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Drug Infusion System market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
Scope of the Report
• The report covers the descriptive overview of Drug Infusion System, explaining its applications, advantages, and limitations, etc.
• Additionally, an all-inclusive account of the currently available Drug Infusion System is provided, which will have an impact on the future market of Drug Infusion System.
• A detailed review of Drug Infusion System market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Drug Infusion System market.
Report Highlights
• The report covers descriptive overview of the Drug Infusion System, explaining its applications, working mechanism, etc.
• The report provides an insight into the patient population eligible for Drug Infusion System in the 7 MM, covering the US, EU5 (Germany, Spain, France, Italy, UK) & Japan.
• The report is a comprehensive account of marketed devices present in the Drug Infusion System market.
• The report also reviews the detailed global historical and forecasted Drug Infusion System market including assessing the outreach in 7 MM.
• The report helps in developing business strategies by understanding trends shaping and driving the global Drug Infusion System market.
Drug Infusion System Report Key Strengths
• 6 Years Forecast
• 7MM Coverage
• Competitive Landscape
• Patient pool
• Market Size
Drug Infusion System Report Assessment
• Marketed Product profiles
• Key Products and Key Players
• Market Drivers and Barriers
• Market Forecast
• KOL’S views
Key Questions
Market Insights:
• What was the Drug Infusion System market share (%) distribution in 2017 and how it will look like in 2025?
• What will be the Drug Infusion System total market Size as well as market Size by devices across the 7MM during the forecast period (2017–2025)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Drug Infusion System market Size during the forecast period (2017–2025)?
• At what CAGR, the Drug Infusion System market is expected to grow in 7mm during the forecast period (2017–2025)?
• What will be the Drug Infusion System market outlook across the 7mm during the forecast period (2017–2025)?
• What will be the Drug Infusion System market growth till 2025 and what will be the resultant market size in the year 2025?
• How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?
Competitive Landscape:
• What are the current devices available in the Drug Infusion System market?
• What is the Drug Infusion System available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
• How many key players are developing Drug Infusion System?
• What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Drug Infusion System?
• What are the key designations that have been granted for the current Drug Infusion System?
• What are the global historical and forecasted market of Drug Infusion System?
'
1. Key Insights
2. Executive Summary of Drug Infusion System
3. Drug Infusion System: Background and Overview
3.1. Introduction
4. Company Profiles
4.1. Company A
4.1.1. Company Overview
4.1.2 Product Portfolio
4.1.2.1 Product description
4.1.2.2 Regulatory Milestones
4.1.2.3 Research and Development
4.1.2.4 Product Development Activities
4.2. Company B
4.2.1.Company Overview
4.2.2 Product Portfolio
4.2.2.1 Product description
4.2.2.2 Regulatory Milestones
4.2.2.3 Research and Development
4.2.2.4 Product Development Activities
Products detail in the report…
5 Drug Infusion System: Competitive Analysis
6. Drug Infusion System Devices: Market Analysis
6.1. Drug Infusion System: Market Analysis in the 7MM (2017–2025)
6.1.1. Drug Infusion System: Market Analysis in the 7MM by type (2017–2025)
6.1.2. Drug Infusion System: Market Analysis in the 7MM by application (2017–2025)
6.1.3. Drug Infusion System: Market Analysis in the 7MM by end user (2017–2025)
6.2. Drug Infusion System: United States Market Analysis (2017–2025)
6.2.1. Drug Infusion System: Market Analysis in the US by type (2017-2025)
6.2.2. Drug Infusion System: Market Analysis in the US by application (2017-2025)
6.2.3. Drug Infusion System: Market Analysis in the US by end user (2017-2025)
6.3. Drug Infusion System: Germany Market Analysis (2017–2025)
6.3.1. Drug Infusion System: Market Analysis in Germany by type (2017-2025)
6.3.2. Drug Infusion System: Market Analysis in Germany by application (2017-2025)
6.3.3. Drug Infusion System: Market Analysis in Germany by end user (2017-2025)
6.4. Drug Infusion System: France Market Analysis (2017–2025)
6.3.1. Drug Infusion System: Market Analysis in France by type (2017-2025)
6.3.2. Drug Infusion System: Market Analysis in France by application (2017-2025)
6.3.3. Drug Infusion System: Market Analysis in France by end user (2017-2025)
6.5. Drug Infusion System: Italy Market Analysis (2017–2025)
6.5.1. Drug Infusion System: Market Analysis in Italy by type (2017-2025)
6.5.2. Drug Infusion System: Market Analysis in Italy by application (2017-2025)
6.5.3. Drug Infusion System: Market Analysis in Italy by end user (2017-2025)
6.6. Drug Infusion System: Spain Market Analysis (2017–2025)
6.6.1. Drug Infusion System: Market Analysis in Spain by type (2017-2025)
6.6.2. Drug Infusion System: Market Analysis in Spain by application (2017-2025)
6.6.3. Drug Infusion System: Market Analysis in Spain by end user (2017-2025)
6.7. Drug Infusion System: United Kingdom Market Analysis (2017–2025)
6.7.1. Drug Infusion System: Market Analysis in the UK by type (2017-2025)
6.7.2. Drug Infusion System: Market Analysis in the UK by application (2017-2025)
6.7.3. Drug Infusion System: Market Analysis in the UK by end user (2017-2025)
6.8. Drug Infusion System: Japan Market Analysis (2017–2025)
6.8.1. Drug Infusion System: Market Analysis in Japan by type (2017-2025)
6.8.2. Drug Infusion System: Market Analysis in Japan by application (2017-2025)
6.8.3. Drug Infusion System: Market Analysis in Japan by end user (2017-2025)
7. Market Drivers
8. Market Barriers
9. Industry Trends
10. KOL’s Views
11. Analyst Views
12. PEST Analysis
13. Appendix
13.1. Bibliography
13.2. Report Methodology
14. DelveInsight Capabilities
15. Disclaimer
16. About DelveInsight
Table 1: Competitive Analysis
Table 2: Drug Infusion System: Market Analysis in the 7MM (2017–2025)
Table 3: Drug Infusion System: Market Analysis in the 7MM by type (2017–2025)
Table 4: Drug Infusion System: Market Analysis in the 7MM by application (2017–2025)
Table 5: Drug Infusion System: Market Analysis in the 7MM by end user (2017–2025)
Table 6: Drug Infusion System: United States Market Analysis (2017–2025)
Table 7: Drug Infusion System: Market Analysis in the US by type (2017-2025)
Table 8: Drug Infusion System: Market Analysis in the US by application (2017-2025)
Table 9: Drug Infusion System: Market Analysis in the US by end user (2017-2025)
Table 10: Drug Infusion System: Germany Market Analysis (2017–2025)
Table 11: Drug Infusion System: Market Analysis in Germany by type (2017-2025)
Table 12: Drug Infusion System: Market Analysis in Germany by application (2017-2025)
Table 13: Drug Infusion System: Market Analysis in Germany by end user (2017-2025)
Table 14: Drug Infusion System: France Market Analysis (2017–2025)
Table 15: Drug Infusion System: Market Analysis in France by type (2017-2025)
Table 16: Drug Infusion System: Market Analysis in France by application (2017-2025)
Table 17: Drug Infusion System: Market Analysis in France by end user (2017-2025)
Table 18: Drug Infusion System: Italy Market Analysis (2017–2025)
Table 19: Drug Infusion System: Market Analysis in Italy by type (2017-2025)
Table 20: Drug Infusion System: Market Analysis in Italy by application (2017-2025)
Table 21: Drug Infusion System: Market Analysis in Italy by end user (2017-2025)
Table 22: Drug Infusion System: Spain Market Analysis (2017–2025)
Table 23: Drug Infusion System: Market Analysis in Spain by type (2017-2025)
Table 24: Drug Infusion System: Market Analysis in Spain by application (2017-2025)
Table 25: Drug Infusion System: Market Analysis in Spain by end user (2017-2025)
Table 26: Drug Infusion System: United Kingdom Market Analysis (2017–2025)
Table 27: Drug Infusion System: Market Analysis in the UK by type (2017-2025)
Table 28: Drug Infusion System: Market Analysis in the UK by application (2017-2025)
Table 29: Drug Infusion System: Market Analysis in the UK by end user (2017-2025)
Table 30: Drug Infusion System: Japan Market Analysis (2017–2025)
Table 31: Drug Infusion System: Market Analysis in Japan by type (2017-2025)
Table 32: Drug Infusion System: Market Analysis in Japan by application (2017-2025)
Table 33: Drug Infusion System: Market Analysis in Japan by end user (2017-2025)
Medtronic
B. Braun Melsungen AG
Baxter
Arcomed AG
Halyard Health, INC
ICU Medical Inc
Insulet Corporation
Terumo Corporation
Smiths Group Plc
Tandem Diabetes Care
